ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Towa Pharmaceutical Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 7.53% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Jun 25
- INTEREST COVERAGE RATIO(Q) Lowest at 1,936.3
- INTEREST(Q) Highest at JPY 540 MM
3
With ROCE of 6.73%, it has a very attractive valuation with a 0.98 Enterprise value to Capital Employed
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 24.47%, its profits have risen by 43.1% ; the PEG ratio of the company is 0.2
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Towa Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Towa Pharmaceutical Co., Ltd. for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Towa Pharmaceutical Co., Ltd.
22.7%
0.74
33.27%
Japan Nikkei 225
28.54%
1.14
25.81%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.65%
EBIT Growth (5y)
7.53%
EBIT to Interest (avg)
46.00
Debt to EBITDA (avg)
3.98
Net Debt to Equity (avg)
1.01
Sales to Capital Employed (avg)
0.66
Tax Ratio
27.89%
Dividend Payout Ratio
18.15%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
6.69%
ROE (avg)
9.32%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.96
EV to EBIT
14.54
EV to EBITDA
7.80
EV to Capital Employed
0.98
EV to Sales
1.30
PEG Ratio
0.21
Dividend Yield
NA
ROCE (Latest)
6.73%
ROE (Latest)
10.56%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
OPERATING CASH FLOW(Y)
Highest at JPY 35,185 MM
CASH AND EQV(HY)
Highest at JPY 98,409 MM
-13What is not working for the Company
INTEREST COVERAGE RATIO(Q)
Lowest at 1,936.3
INTEREST(Q)
Highest at JPY 540 MM
Here's what is working for Towa Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at JPY 35,185 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (JPY MM)
Cash and Eqv
Highest at JPY 98,409 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Towa Pharmaceutical Co., Ltd.
Interest
At JPY 540 MM has Grown at 16.13%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Interest Coverage Ratio
Lowest at 1,936.3
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
Highest at JPY 540 MM
in the last five periods and Increased by 16.13% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
